Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Asia Pacific Prostate Cancer Conference /
Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC

1st - 2nd Mar 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 12.05.14
Views: 2770

Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany;

Dr Kurt Miller from Berlin, Germany, reviews the novel non-androgen receptor (AR) therapeutic targets in CRPC. Outlining the different mechanisms by which CRPC develops, Dr Miller explains why non-AR targets are valid, and reviews the treatments available and in the pipeline.

This video is sponsored by an educational grant from Janssen Asia Pacific, a pharmaceutical company of Johnson & Johnson

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation